Fibroblast growth factor 2 is of prognostic value for patients with locally advanced squamous cell carcinoma of the head and neck

Hyperfractionated accelerated radiotherapy with concomitant integrated boost of 70–75 Gy in 5 weeks for advanced head and neck cancer

(2012) J. Cvek et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Methods for estimating the site of origin of locoregional recurrence in head and neck squamous cell carcinoma

(2012) A.K. Due et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Impact of intensity-modulated and image-guided radiotherapy on elderly patients undergoing chemoradiation for locally advanced head and neck cancer

(2012) N.P. Nguyen et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Prognostic factors (including HPV status) for irradiation of locally advanced squamous cell carcinoma of the head and neck (SCCHN)

(2011) Dirk Rades et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Prognostic factors for survival and tumor control in cervical lymph node metastases from head and neck cancer: A multivariate study of 492 cases

(2010) Laura Cerezo et al.   CANCER

Fibroblast Growth Factor 2—A Predictor of Outcome for Patients Irradiated for Stage II-III Non–Small-Cell Lung Cancer

(2010) Dirk Rades et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Locally Advanced Stage IV Squamous Cell Carcinoma of the Head and Neck: Impact of Pre-Radiotherapy Hemoglobin Level and Interruptions During Radiotherapy

(2007) Dirk Rades et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS